vs
MANNKIND CORP（MNKD）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是MANNKIND CORP的1.7倍（$188.3M vs $112.0M），BRC Group Holdings, Inc.净利率更高（47.9% vs -14.2%，领先62.2%），MANNKIND CORP同比增速更快（45.8% vs -21.9%），过去两年MANNKIND CORP的营收复合增速更高（30.0% vs -15.4%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
MNKD vs RILY — 直观对比
营收规模更大
RILY
是对方的1.7倍
$112.0M
营收增速更快
MNKD
高出67.7%
-21.9%
净利率更高
RILY
高出62.2%
-14.2%
两年增速更快
MNKD
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $188.3M |
| 净利润 | $-15.9M | $90.3M |
| 毛利率 | 87.6% | 79.5% |
| 营业利润率 | -6.9% | 32.3% |
| 净利率 | -14.2% | 47.9% |
| 营收同比 | 45.8% | -21.9% |
| 净利润同比 | -314.9% | 1710.8% |
| 每股收益（稀释后） | $-0.05 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRILY
| Q4 25 | $112.0M | $188.3M | ||
| Q3 25 | $82.1M | $215.3M | ||
| Q2 25 | $76.5M | $188.2M | ||
| Q1 25 | $78.4M | $197.2M | ||
| Q4 24 | $76.8M | $241.0M | ||
| Q3 24 | $70.1M | $225.5M | ||
| Q2 24 | $72.4M | $256.0M | ||
| Q1 24 | $66.3M | $263.4M |
净利润MNKDRILY
| Q4 25 | $-15.9M | $90.3M | ||
| Q3 25 | $8.0M | $91.1M | ||
| Q2 25 | $668.0K | $139.5M | ||
| Q1 25 | $13.2M | $-10.0M | ||
| Q4 24 | $7.4M | $-5.6M | ||
| Q3 24 | $11.6M | $-284.4M | ||
| Q2 24 | $-2.0M | $-433.6M | ||
| Q1 24 | $10.6M | $-49.2M |
毛利率MNKDRILY
| Q4 25 | 87.6% | 79.5% | ||
| Q3 25 | 94.5% | 83.7% | ||
| Q2 25 | 94.0% | 81.3% | ||
| Q1 25 | 95.2% | 81.4% | ||
| Q4 24 | 93.7% | 79.8% | ||
| Q3 24 | 95.4% | 82.1% | ||
| Q2 24 | 92.3% | 84.5% | ||
| Q1 24 | 94.2% | 85.3% |
营业利润率MNKDRILY
| Q4 25 | -6.9% | 32.3% | ||
| Q3 25 | 23.0% | 30.4% | ||
| Q2 25 | 6.9% | 5.7% | ||
| Q1 25 | 28.5% | -31.2% | ||
| Q4 24 | 34.5% | -69.2% | ||
| Q3 24 | 18.2% | -36.4% | ||
| Q2 24 | 22.9% | -90.8% | ||
| Q1 24 | 25.2% | -6.1% |
净利率MNKDRILY
| Q4 25 | -14.2% | 47.9% | ||
| Q3 25 | 9.7% | 42.3% | ||
| Q2 25 | 0.9% | 74.1% | ||
| Q1 25 | 16.8% | -5.1% | ||
| Q4 24 | 9.7% | -2.3% | ||
| Q3 24 | 16.5% | -126.1% | ||
| Q2 24 | -2.8% | -169.4% | ||
| Q1 24 | 16.0% | -18.7% |
每股收益（稀释后）MNKDRILY
| Q4 25 | $-0.05 | $2.78 | ||
| Q3 25 | $0.03 | $2.91 | ||
| Q2 25 | $0.00 | $4.50 | ||
| Q1 25 | $0.04 | $-0.39 | ||
| Q4 24 | $0.03 | $-0.01 | ||
| Q3 24 | $0.04 | $-9.39 | ||
| Q2 24 | $-0.01 | $-14.35 | ||
| Q1 24 | $0.04 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $226.6M |
| 总债务越低越好 | $354.6M | $1.4B |
| 股东权益账面价值 | $-51.0M | $-171.5M |
| 总资产 | $792.2M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MNKDRILY
| Q4 25 | $171.3M | $226.6M | ||
| Q3 25 | $260.0M | $184.2M | ||
| Q2 25 | $179.0M | $267.4M | ||
| Q1 25 | $181.5M | $138.3M | ||
| Q4 24 | $197.3M | $146.9M | ||
| Q3 24 | $251.6M | $159.2M | ||
| Q2 24 | $247.8M | $236.9M | ||
| Q1 24 | $300.7M | $190.7M |
总债务MNKDRILY
| Q4 25 | $354.6M | $1.4B | ||
| Q3 25 | $109.7M | $1.3B | ||
| Q2 25 | $36.2M | $1.3B | ||
| Q1 25 | $36.1M | $1.4B | ||
| Q4 24 | $36.1M | $1.5B | ||
| Q3 24 | $227.9M | — | ||
| Q2 24 | $227.6M | — | ||
| Q1 24 | $264.1M | — |
股东权益MNKDRILY
| Q4 25 | $-51.0M | $-171.5M | ||
| Q3 25 | $-44.6M | $-260.5M | ||
| Q2 25 | $-55.0M | $-351.7M | ||
| Q1 25 | $-58.6M | $-496.8M | ||
| Q4 24 | $-78.8M | $-488.2M | ||
| Q3 24 | $-209.9M | $-497.6M | ||
| Q2 24 | $-225.8M | $-218.3M | ||
| Q1 24 | $-230.0M | $228.4M |
总资产MNKDRILY
| Q4 25 | $792.2M | $1.7B | ||
| Q3 25 | $494.6M | $1.7B | ||
| Q2 25 | $411.7M | $1.5B | ||
| Q1 25 | $410.1M | $1.5B | ||
| Q4 24 | $393.8M | $1.8B | ||
| Q3 24 | $464.2M | $2.2B | ||
| Q2 24 | $443.8M | $3.2B | ||
| Q1 24 | $480.9M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | — |
| 自由现金流率自由现金流/营收 | -8.9% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $13.7M | — |
8季度趋势，按日历期对齐
经营现金流MNKDRILY
| Q4 25 | $-8.0M | $26.2M | ||
| Q3 25 | $23.6M | $-60.6M | ||
| Q2 25 | $8.9M | $-25.6M | ||
| Q1 25 | $-6.4M | $184.0K | ||
| Q4 24 | $22.6M | $-2.7M | ||
| Q3 24 | $9.3M | $19.5M | ||
| Q2 24 | $3.8M | $111.5M | ||
| Q1 24 | $6.7M | $135.4M |
自由现金流MNKDRILY
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $-6.7M | — | ||
| Q4 24 | $19.7M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $861.0K | — | ||
| Q1 24 | $4.3M | — |
自由现金流率MNKDRILY
| Q4 25 | -8.9% | — | ||
| Q3 25 | 27.4% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 25.7% | — | ||
| Q3 24 | 11.3% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 6.5% | — |
资本支出强度MNKDRILY
| Q4 25 | 1.8% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 3.6% | — |
现金转化率MNKDRILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | 2.96× | -0.66× | ||
| Q2 25 | 13.40× | -0.18× | ||
| Q1 25 | -0.48× | — | ||
| Q4 24 | 3.05× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
